University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Biktarvy

bictegravir + tenofovir alafenamide + Emtriva (Biktarvy)

Type of Drug: Fixed-Dose Combination
Fixed-dose combinations combine the most commonly prescribed doses of 2 or more medications into a single pill.

Approved adult dosing

Bictegravir 50 mg + tenofovir alafenamide 25 mg + Emtriva 200 mg in a single tablet

One Biktarvy once daily

  • Once daily

    Biktarvy

    Biktarvy

Notes on taking this medication

  • No food restrictions; you can take Biktarvy with or without food.
  • Before taking Biktarvy, you should be tested to see if you have hepatitis B.
  • Biktarvy can interact with other drugs; consult your medical provider.
  • Antacids, laxatives, mineral supplements, and other compounds that contain calcium, magnesium, aluminum, or iron can decrease levels of Biktarvy if they are taken close in time to each other. Ask your provider whether or how you can take these compounds with Biktarvy.
  • People with severe kidney problems may not be able to take this combination pill.

Possible side effects

  • Biktarvy has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

See accompanying chart: Tips for Common Side Effects

Same possible side effects as

Bictegravir

  • Usually well tolerated; may cause headache, nausea, or diarrhea

Tenofovir alafenamide

  • Gassiness; abdominal discomfort; nausea; diarrhea
  • Kidney impairment
  • Tenofovir alafenamide is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

Emtriva

  • Skin discoloration (particularly in dark-skinned people)
  • Emtriva is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Contents
Scroll over drug name to see other names for the drug.